Planta Med 1997; 63(2): 141-145
DOI: 10.1055/s-2006-957631
Papers
Pharmacology and Molecular Biology
© Georg Thieme Verlag Stuttgart · New York

Inhibitory Effects of Oren-Gedoku-to and its Components on Cholesteryl Ester Synthesis in Cultured Human Hepatocyte HepG2 Cells: Evidence from the Cultured Hep2G Cells and In Vitro Assay of ACAT

H. Yotsumoto1 , T. Yanagita1 , K. Yamamoto2 , Y. Ogawa2 , J. Y. Cha1 , Y. Mori1
  • 1Department of Applied Biological Sciences, Saga University, Saga 840, Japan
  • 2Department of Internal Medicine, Saga Medical School, Saga 840, Japan
Further Information

Publication History

1996

1996

Publication Date:
04 January 2007 (online)

Abstract

The pharmacological effects of Oren-gedoku-to (OGT), a Japanese-Chinese traditional herbal medicinal mixture, on lipid biosynthesis were investigated in cultured human hepatocyte HepG2 cells. The addition of OGT (0.5 and 4.2 mg/ml), which had no effect on cell proliferation and cellular protein content, caused a marked decrease in the cellular cholesterol content, particularly cholesteryl ester content following 24 h incubation. The incorporation of 14 C-oleate into cellular cholesteryl ester fraction was also reduced remarkably during incubation for 6 and 24 h. The effects of OGT, its components and its main active chemicals on acyl-coenzyme A:cholesterol acyltransferase (ACAT) activity were studied in vitro to explore the mechanism by which OGT inhibits cholesteryl ester formation. The data confirmed that OGT, in a dose-dependent manner, and its components (Scutellaria baicalensis, Coptis japonica, Gardenia jasminoides and Phelloden-dron amurense) remarkably inhibit ACAT activity. Among the main active chemicals of OGT, baicalein, a kind of flavonoid, decreased ACAT activity in a dose-dependent fashion from the level of 10-6M. These results strongly suggest that OGT reduces the cholesteryl ester formation in human hepatocytes by inhibiting ACAT, and that baicalein may, in part, be responsible for ACAT inhibition.

    >